CSACI position statement: prescribing sublingual immunotherapy tablets for aeroallergens
Open Access
- 9 January 2018
- journal article
- review article
- Published by Springer Science and Business Media LLC in Allergy, Asthma & Clinical Immunology
- Vol. 14 (1), 1-4
- https://doi.org/10.1186/s13223-017-0225-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Allergy immunotherapyCurrent Opinion in Allergy and Clinical Immunology, 2014
- Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta-analysis of randomized, double-blind and placebo-controlled trialsThe Clinical Respiratory Journal, 2014
- Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and costJournal of Evaluation in Clinical Practice, 2014
- Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and AsthmaJAMA, 2013
- The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patientsAllergy, Asthma & Clinical Immunology, 2012
- Allergic rhinitisAllergy, Asthma & Clinical Immunology, 2011
- Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta‐analysisClinical & Experimental Allergy, 2011
- Systematic reviews of sublingual immunotherapy (SLIT)Allergy, 2011
- Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adultsJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescentsJournal of Allergy and Clinical Immunology, 2011